Descripción de la oferta
About IJC The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research centre dedicated to conducting research and driving innovation in the epidemiological, preventive, clinical, translational and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. Since its creation in 2010, IJC has experienced exponential growth and has been accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation and Universities in 2024. IJC is part of the network of Excellence Research Centres of Catalonia (CERCA) and also an integrated research institute within the Institut de Recerca Germans Trias i Pujol (IGTP), accredited by the Carlos III Health Institute (ISCIII) and by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC). Location The IJC’s main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting‑edge scientific and technological facilities and complementary community services. It has six oncology locations – Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Trueta, Hospital del Mar, and Hospital San Joan de Déu – which facilitate close collaboration between basic and clinical researchers and foster translational research. Research Description The “3D Chromatin Organization Group”, led by Dr. Biola M. Javierre, focuses on understanding the role of distal regulatory elements in gene transcription and malignant transformation. The position is funded by the grant PREP (MICIU/AEI) and by FSE+, and is associated with the PID NB‑I00 contract. The research aims to develop and apply advanced multi‑omics approaches to map distal regulatory elements (DREs), identify their target genes, and integrate non‑coding mutations to uncover causal variants in haematological cancers, ultimately improving patient outcomes. Techniques will include functional assays, preclinical models and CRISPR‑based genome editing. What We Need MSc degree in immunology, epigenetics, biomedicine, molecular biology, cancer biology or a related field, or a MSc in bioinformatics or a related field. A committed scientist with a competitive scientific record and experience in epigenetics, molecular biology, biomedicine, bioinformatics or a related discipline. Both wet‑ and dry‑lab profiles are welcome. Ability to manage varying workloads and work well in a team. Strong collaborative and communicative skills. Good level of English speaking and writing skills (required). High motivation and interest in research. Excellent communication skills. What We Offer FPI PhD position for four years. Contract associated with the grant PREP (MICIU/AEI) and FSE+. Full‑time contract (1,623 hours per year). Opportunities for training and professional development. Incorporation into a multinational and highly collaborative team. Work on a new strategic platform within the Institute. Mixed basic and clinical research environment at IJC. Work‑life balance measures (flexible work schedule, vacation days, personal matters). Flexible remuneration program including kindergarten support. The stimulating environment of IJC and its scientific network. Evaluation Criteria Academic and/or scientific‑technical track record (up to 50 points) Scientific and technical contributions (up to 45 points). Mobility and internationalisation (up to 5 points). Suitability for the research activities (up to 50 points) Deadline for Applications Please submit your application by the 10th of May 2026. Equal Opportunity IJC is an equal‑opportunity employer. We evaluate qualified applicants without regard to race, colour, religion, sex, national origin, disability, or other legally protected characteristics. #J-18808-Ljbffr
